NYSE:BSX

Boston Scientific - BSX Stock Forecast, Price & News

$48.22

+0.28 (+0.58%)

(As of 03/24/2023 12:00 AM ET)

Add

Compare

Today's Range: $47.52
▼
$48.31
50-Day Range: $45.09
▼
$48.84
52-Week Range: $34.98
▼
$49.22

Volume: 10.07 million shs
Average Volume: 8.05 million shs
Market Capitalization: $69.19 billion

P/E Ratio: 107.16
Dividend Yield: N/A
Price Target: $51.50

Institutional Ownership

Boston Scientific MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 6.8% Upside
$51.50 Price Target
Short Interest: Healthy
0.88% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.98
Upright™ Environmental Score
News Sentiment: 0.05
Based on 34 Articles This Week
Insider Trading: Selling Shares
$5.75 M Sold Last Quarter
Proj. Earnings Growth: 13.16%
From $1.90 to $2.15 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.99 out of 5 stars

Medical Sector

447th out of 989 stocks

Surgical & Medical Instruments Industry

42nd out of 99 stocks

1.5

Analyst's Opinion

Consensus Rating
Boston Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 12 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $51.50, Boston Scientific has a forecasted upside of 6.8% from its current price of $48.22.
Amount of Analyst Coverage
Boston Scientific has only been the subject of 4 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.88% of the outstanding shares of Boston Scientific have been sold short.
Short Interest Ratio / Days to Cover
Boston Scientific has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Boston Scientific has recently increased by 29.89%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Boston Scientific does not currently pay a dividend.
Dividend Growth
Boston Scientific does not have a long track record of dividend growth.

4.4

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Boston Scientific has received a 67.96% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Neurostimulators", "Cardiac resynchronization therapy (CRT) devices", and "Penile implants" products. See details.
Environmental Sustainability
The Environmental Impact score for Boston Scientific is -0.98.

1.7

News and Social Media Coverage

News Sentiment
Boston Scientific has a news sentiment score of 0.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 34 news articles for Boston Scientific this week, compared to 10 articles on an average week.
Search Interest
Only 18 people have searched for BSX on MarketBeat in the last 30 days. This is a decrease of -69% compared to the previous 30 days.
MarketBeat Follows
Only 11 people have added Boston Scientific to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Boston Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,754,217.00 in company stock.
Percentage Held by Insiders
Only 0.71% of the stock of Boston Scientific is held by insiders.
Percentage Held by Institutions
90.23% of the stock of Boston Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Boston Scientific are expected to grow by 13.16% in the coming year, from $1.90 to $2.15 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Boston Scientific is 107.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.58.
Price to Earnings Ratio vs. Sector
The P/E ratio of Boston Scientific is 107.16, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 86.26.
Price to Earnings Growth Ratio
Boston Scientific has a PEG Ratio of 2.27. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Boston Scientific has a P/B Ratio of 3.93. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Boston Scientific (NYSE:BSX) Stock

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Urology and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.

Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

BSX Stock News Headlines

March 23, 2023 | finance.yahoo.com

Boston Scientific (NYSE:BSX) shareholders have earned a 12% CAGR over the last five years

March 22, 2023 | 247wallst.com

Unusual Put Option Trade in Boston Scientific Worth $265K

March 25, 2023 | Weiss Ratings (Ad)

Bank Accounts: Frozen!

In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!

March 21, 2023 | msn.com

‘A few’ Boston school students taken to hospital after consuming edibles, district says

March 21, 2023 | msn.com

Boston weather: Here’s what to expect from Wednesday’s forecast

March 21, 2023 | msn.com

Boston homicide detectives investigating serious assault near Downtown Crossing

March 21, 2023 | finance.yahoo.com

Boston Scientific's Wicked Rally Can Take the Stock 20% Higher

March 21, 2023 | sportsbookwire.usatoday.com

Boston Bruins vs. Ottawa Senators odds, tips and betting trends

March 25, 2023 | Investor Place Media (Ad)

Biden To Unleash "Choke Point" Operation On America?

Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.

March 21, 2023 | msn.com

Boston police ask for help finding missing 14-year-old Roxbury girl

March 21, 2023 | msn.com

Bruins legend Zdeno Chara to run first Boston Marathon for The Hoyt Foundation, Thomas E. Smith Foundation

March 20, 2023 | msn.com

Boston weather: Here’s what to expect from Tuesday’s forecast

March 20, 2023 | msn.com

How Boston.com sportswriters answered the debate over Boston’s greatest sports comeback

March 20, 2023 | msn.com

Boston City Council to discuss proposed ban on 'nips'

March 19, 2023 | msn.com

Zdeno Chara to run Boston Marathon for Team Hoyt, Thomas E. Smith Foundation

March 19, 2023 | msn.com

South Boston’s St. Patrick’s day breakfast serves up barbs for the departed

March 19, 2023 | msn.com

Boston man accused of trying to throw ‘imposter’ wife into Fort Point Channel

March 19, 2023 | msn.com

Boston weather: Here’s what to expect from Monday’s forecast

March 19, 2023 | msn.com

South Boston residents, tourists, and businesses gear up for St. Patrick's Day Parade

March 19, 2023 | msn.com

Parade day in Boston: Everything you need to know

March 19, 2023 | msn.com

MBTA ramps up service for St. Patrick's Day Parade in Boston

March 19, 2023 | americanbankingnews.com

StockNews.com Begins Coverage on Boston Scientific (NYSE:BSX)

March 18, 2023 | msn.com

Boston man accused of attempting to throw 'imposter' wife into Fort Point Channel

March 18, 2023 | msn.com

Boston police ask for public’s help in locating missing 14-year-old

March 18, 2023 | sportsbookwire.usatoday.com

Boston Bruins vs. Minnesota Wild odds, tips and betting trends

March 18, 2023 | msn.com

Boston man threatens subway riders with pet rat Jerry: Police

March 18, 2023 | nasdaq.com

BSX November 17th Options Begin Trading

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

BSX Company Calendar

Last Earnings: 2/01/2023
Today: 3/25/2023
Next Earnings (Estimated): 4/26/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NYSE:BSX
CUSIP: 10113710
CIK: 885725
Web: www.bostonscientific.com
Phone: (508) 683-4000
Fax: 508-683-5675
Employees: 45,000
Year Founded: 1979

Price Target and Rating

Average Stock Price Forecast: $51.50
High Stock Price Forecast: $56.00
Low Stock Price Forecast: $43.00
Forecasted Upside/Downside: +6.8%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 14 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.45
Trailing P/E Ratio: 107.16
Forward P/E Ratio: 25.38
P/E Growth: 2.3
Net Income: $698 million
Net Margins: 5.50%
Pretax Margin: 9.00%
Return on Equity: 14.29%
Return on Assets: 7.67%

Debt

Debt-to-Equity Ratio: 0.51
Current Ratio: 1.51
Quick Ratio: 1.02

Sales & Book Value

Annual Sales: $12.68 billion
Price / Sales: 5.46
Cash Flow: $2.57 per share
Price / Cash Flow: 18.77
Book Value: $12.27 per share
Price / Book: 3.93

Miscellaneous

Outstanding Shares: 1,434,780,000
Free Float: 1,424,593,000
Market Cap: $69.19 billion
Optionable: Optionable
Beta: 0.79

Social Links

Key Executives

Michael F. Mahoney
Chairman, President & Chief Executive Officer

John Bradley Sorenson
Executive Vice President-Global Operations

Daniel J. Brennan
Chief Financial Officer & Executive Vice President

Jodi Eddy
Senior VP, Chief Information & Digital Officer

Ian T. Meredith
Global Chief Medical Officer & Executive VP

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

BSX Stock - Frequently Asked Questions

Should I buy or sell Boston Scientific stock right now?: 14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 1 hold rating, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BSX shares.
View BSX analyst ratings or view top-rated stocks.
What is Boston Scientific's stock price forecast for 2023?: 14 Wall Street research analysts have issued 1 year price targets for Boston Scientific's stock. Their BSX share price forecasts range from $43.00 to $56.00. On average, they predict the company's share price to reach $51.50 in the next year. This suggests a possible upside of 6.8% from the stock's current price.
View analysts price targets for BSX or view top-rated stocks among Wall Street analysts.
How have BSX shares performed in 2023?: Boston Scientific's stock was trading at $46.27 at the start of the year. Since then, BSX stock has increased by 4.2% and is now trading at $48.22.
View the best growth stocks for 2023 here.
Are investors shorting Boston Scientific?: Boston Scientific saw a increase in short interest in February. As of February 28th, there was short interest totaling 12,690,000 shares, an increase of 29.9% from the February 13th total of 9,770,000 shares. Based on an average trading volume of 6,880,000 shares, the short-interest ratio is currently 1.8 days.
View Boston Scientific's Short Interest.
When is Boston Scientific's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 26th 2023.
View our BSX earnings forecast.
How were Boston Scientific's earnings last quarter?: Boston Scientific Co. (NYSE:BSX) posted its quarterly earnings data on Wednesday, February, 1st. The medical equipment provider reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.47 by $0.02. The medical equipment provider had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.24 billion. Boston Scientific had a net margin of 5.50% and a trailing twelve-month return on equity of 14.29%. The business's revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.45 earnings per share.
Read the conference call transcript.
What ETFs hold Boston Scientific's stock?: ETFs with the largest weight of Boston Scientific (NYSE:BSX) stock in their portfolio include iShares U.S. Medical Devices ETF (IHI), Goldman Sachs Future Health Care Equity ETF (GDOC), Global X Aging Population ETF (AGNG), Invesco Dynamic Market ETF (PWC), BlackRock Future Health ETF (BMED), Putnam Sustainable Leaders ETF (PLDR), JPMorgan Social Advancement ETF (UPWD) and First Trust Indxx Medical Devices ETF (MDEV).
What guidance has Boston Scientific issued on next quarter's earnings?: Boston Scientific updated its FY23 earnings guidance on Wednesday, February, 1st. The company provided earnings per share (EPS) guidance of $1.86-1.93 for the period, compared to the consensus earnings per share estimate of $1.93. The company issued revenue guidance of ~$13.32-13.57 billion, compared to the consensus revenue estimate of $13.45 billion.

What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?: 947 employees have rated Boston Scientific Chief Executive Officer Michael F. Mahoney on Glassdoor.com. Michael F. Mahoney has an approval rating of 98% among the company's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Boston Scientific own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and Salesforce (CRM).
What is Boston Scientific's stock symbol?: Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."
Who are Boston Scientific's major shareholders?: Boston Scientific's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (1.74%), Bollard Group LLC (1.71%), DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main (1.63%), Artisan Partners Limited Partnership (1.36%), Moneta Group Investment Advisors LLC (1.30%) and Amundi (1.00%). Insiders that own company stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, David A Pierce, David S Wichmann, Edward F Mackey, Eric Francis Yves Thepaut, Ian T Meredith, Jeffrey B Mirviss, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, Jonathan Monson, Joseph Michael Fitzgerald, Maulik Nanavaty, Meghan Scanlon, Michael F Mahoney, Michael F Mahoney, Nelda J Connors, Scott Olson, Wendy Carruthers and William F Bruss.
View institutional ownership trends.
How do I buy shares of Boston Scientific?: Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Boston Scientific's stock price today?: One share of BSX stock can currently be purchased for approximately $48.22.
How much money does Boston Scientific make?: Boston Scientific (NYSE:BSX) has a market capitalization of $69.19 billion and generates $12.68 billion in revenue each year. The medical equipment provider earns $698 million in net income (profit) each year or $0.45 on an earnings per share basis.
How many employees does Boston Scientific have?: The company employs 45,000 workers across the globe.
Does Boston Scientific have any subsidiaries?: The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation.
Read More
How can I contact Boston Scientific?: Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The official website for the company is www.bostonscientific.com. The medical equipment provider can be reached via phone at (508) 683-4000, via email at bsxinvestorrelations@bsci.com, or via fax at 508-683-5675.

This page (NYSE:BSX) was last updated on 3/25/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Boston Scientific - BSX Stock Forecast, Price & News

Boston Scientific MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Boston Scientific (NYSE:BSX) Stock

BSX Stock News Headlines

BSX Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

BSX Stock - Frequently Asked Questions

Overall MarketRank^™